RETATRUTIDE – Retatrutide Research | GLP-1/GIP/Glucagon Triple Agonist

Retatrutide research represents a significant advancement in the study of tri-agonist peptides. This innovative research compound, developed for scientific studies on GLP-1, GIP, and glucagon receptors, offers researchers a unique investigative tool. Our laboratory-grade Retatrutide is exclusively intended for in vitro research and laboratory applications.

Properties of Retatrutide in Scientific Research

Mechanism of Action Studied:

• GLP-1 Agonism: Study of incretin receptors
• GIP Agonism: Research on insulinotropic peptide
• Glucagon Agonism: Investigation of metabolic pathways
• Applications: Fundamental research only

Technical Specifications of Retatrutide

• Purity: >98% (HPLC analysis)
• Formulation: Sterile lyophilized
• Storage: -20°C for optimal stability
• Solubility: Bacteriostatic water for reconstitution

Don’t forget your Pfizer bacteriostatic water for reconstitution.

Key Benefits of Retatrutide

• Advanced Weight Loss: reduces fat mass while controlling appetite.
• Triple Hormonal Action: GLP-1, GIP, and glucagon combination for enhanced efficacy.
• Glycemic Regulation: improves glucose metabolism and insulin sensitivity.
• Muscle Preservation: fat loss without lean mass loss.
• Weekly Injection: extended formulation for constant metabolic support.

Safety and Recommendations

Administration should be gradual in order to reduce possible gastrointestinal effects.
Retatrutide is not suitable for everyone: people with a thyroid or pancreatic history should consult a healthcare professional before use.

Storage

After reconstitution, keep refrigerated.
Use the solution within 60 days.

Disclaimer: Retatrutide is strictly for research purposes. Scientific or medical supervision is essential to ensure responsible and safe use.